T-Cypher Bio Limited, in partnership with the University of Hull, is looking to recruit a dynamic and highly driven graduate with relevant biomedical skills who will lead the implementation and development of a customised microfluidics device. The novel technology aims to improve oncology patient outcomes by developing a physiologically relevant system for testing the effectiveness and safety of cancer immunotherapies.

This Knowledge Transfer Partnership (KTP) project is an exciting and rare opportunity that will bring together knowledge of tissue microfluidic expertise, medical device design and implementation to deliver new technology. It is essential that you understand how KTP works with business & the University, and the vital role you will play. For information about KTPs please visit

Full information can be found here -